Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROE

Related VIVO
Meridian Bioscience Slips to Hold - Analyst Blog
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROA
Related NEOG
Neogen Meets Q3 Earnings Ests, Beats Rev - Analyst Blog
Earnings Scheduled For March 25, 2014

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 22.58%. Meridian Bioscience's revenue for the same period is $171.20 million.

The trailing-twelve-month return on equity at Neogen (NASDAQ: NEOG) is 10.90%. Neogen's operating margin for the same period is 18.46%.

The trailing-twelve-month return on equity at Trinity Biotech plc (NASDAQ: TRIB) is 10.77%. Trinity Biotech's profit margin for the same period is 20.71%.

The trailing-twelve-month return on equity at Abaxis (NASDAQ: ABAX) is 8.20%. Abaxis' PEG ratio is 2.69.

Posted-In: Diagnostic Substances Industry highest ROE small-capTrading Ideas

 

Most Popular

Related Articles (ABAX + NEOG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free